BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18802701)

  • 1. The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.
    Yildirim B; Oztürk MA; Unal S
    Rheumatol Int; 2009 Feb; 29(4):477-8. PubMed ID: 18802701
    [No Abstract]   [Full Text] [Related]  

  • 2. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
    Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
    Arabaci T; Kara C; Ciçek Y
    J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine patches for aphthous ulcers due to Behçet's syndrome.
    Scheid P; Bohadana A; Martinet Y
    N Engl J Med; 2000 Dec; 343(24):1816-7. PubMed ID: 11185607
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.
    Mumcu G; Hayran O; Ozalp DO; Inanc N; Yavuz S; Ergun T; Direskeneli H
    J Oral Pathol Med; 2007 Mar; 36(3):147-52. PubMed ID: 17305636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
    Lee JH; Jung JY; Bang D
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal: Improvement of refractory oral ulcer of Behçet's disease after eradication of Helicobacter pylori.
    Okano A; Ohana M
    J Gastroenterol Hepatol; 2018 Mar; 33(3):560. PubMed ID: 29469234
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L; Horowitz I; Kay B
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection in oral lesions of patients with recurrent aphthous stomatitis.
    Mansour-Ghanaei F; Asmar M; Bagherzadeh AH; Ekbataninezhad S
    Med Sci Monit; 2005 Dec; 11(12):CR576-9. PubMed ID: 16319788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide for treatment of recurrent oral aphthae in Adamantiades-Behçet's disease.
    Ossorio-García L; Jiménez-Gallo D; de la Varga-Martínez R; Linares-Barrios M
    J Dtsch Dermatol Ges; 2018 Aug; 16(8):1029-1031. PubMed ID: 29998511
    [No Abstract]   [Full Text] [Related]  

  • 12. Can therapeutic considerations provide clues to the etiology of aphthous stomatitis and Behçet's syndrome?
    Rytel MW
    J Oral Pathol; 1978; 7(6):372-5. PubMed ID: 105095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recurrent aphthous stomatitis case due to paediatric Behçet's disease.
    Unal M; Yildirim SV; Akbaba M
    J Laryngol Otol; 2001 Jul; 115(7):576-7. PubMed ID: 11485594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pentoxifylline in the treatment of orogenital aphthosis and Behçet's syndrome].
    Pizarro A; Herranz P; García-Tobaruelaa A; Casado M
    Med Clin (Barc); 2000 Nov; 115(17):678. PubMed ID: 11141422
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of dapsone in Behcet's disease.
    Convit J; Goihman-Yahr M; Rondón-Lugo AJ
    Br J Dermatol; 1984 Nov; 111(5):629-30. PubMed ID: 6498097
    [No Abstract]   [Full Text] [Related]  

  • 17. Colitis of Behçet's syndrome.
    Fallingborg J; Laustsen J
    Acta Med Scand; 1984; 215(4):397-9. PubMed ID: 6731050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of Apremilast in idiopathic recurrent aphthous stomatitis: Review of two clinical cases].
    Fourmond S; Gutierrez B; Gourin MP; Delaumenie S; Ly KH
    Rev Med Interne; 2022 May; 43(5):312-315. PubMed ID: 35219509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Apremilast for Aphthous Ulcers in a Patient With Behçet’s Syndrome.
    Saini A; Ferguson C; Salkey K
    J Drugs Dermatol; 2018 Dec; 17(12):1328-1329. PubMed ID: 30586267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet's disease.
    Monastirli A; Chroni E; Georgiou S; Ellul J; Pasmatzi E; Papathanasopoulos P; Tsambaos D
    QJM; 2010 Oct; 103(10):787-90. PubMed ID: 20650970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.